Approval · Notice of Compliance 219 · 2002
ABENOL: Notice of Compliance 219
Issued February 19, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 219
- Date
- February 19, 2002
- Company
- Glaxosmithkline Consumer Healthcare UlcMississauga, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Analgesic, antipyretic
Products in this notice
Medicinal ingredients
- ACETAMINOPHEN 120 MG per SUP
- ACETAMINOPHEN 325 MG per SUP
- ACETAMINOPHEN 650 MG per SUP